The final webinar in our Cancer-Immunity Cycle Series includes a panel discussion of key topics in the field of cancer immunotherapy, including new and emerging methods, recent publications, and future directions. The links between preclinical research, in vivo studies, and biomarkers are explored, as well as the unique advantages of Crown Bioscience and their service offerings.

Key learning objectives:
  • How our understanding of the cancer immunity cycle impacts cancer immunotherapy development

  • Which new in vitro technologies provide more physiological and translatable drug responses

  • Why HCI is providing deeper insights into drug responses

  • What novel solutions are on the horizon to overcome the challenges of immunotherapeutic development
Gera Goverse, PhD
Director of Immuno-Oncology
Trained as an immunologist, Gera has used novel technologies to study the role of different environmental factors on both the local and systemic immune system to suppress their responses in inflammatory disorders and in the field of immuno-oncology.

Since joining the team at Crown Bioscience, Gera has executed the design of many successful immuno-oncology projects to help national and international customers discover the full potential of their compounds.

Gera is motivated by studying the complex mechanisms of the regulation of the immune system, exploring tumor-cell interactions and refining ways to stimulate the immune responses towards the killing of the tumor.
Leo Price, PhD
Senior Vice President of In Vitro, Head of Crown Bioscience Netherlands
Leo Price leads Crown Bioscience’s in vitro services in Europe and the US and the Crown Bioscience sites in The Netherlands, Leiden and Utrecht. He joined Crown Bioscience in 2021 from OcellO, following Crown Bioscience’s acquisition of the company. Dr Price was the founder of OcellO, a leading provider of high content screening services, using organoids and other advanced 3D cell culture models, and served as their CEO and CSO for ten years.

Prior to founding OcellO, Leo was a Faculty Member and Group Leader at Leiden University for five years and completed three postdoctoral studies with UMC Utrecht, The Netherlands Cancer Institute and Scripps Research Institute. He received his PhD in Cell Physiology from University College London and is currently a guest Associate Professor at the Leiden Academic Centre for Drug Research, Leiden University.
Ludovic Bourre, PhD
Vice President, Reserach & Innovation
Ludovic started his career studying pharmacology focusing on drug delivery systems using peptide targeting and nanotechnology approach as a postdoctoral researcher at University College London and University College Cork. He then held various positions in preclinical CROs working on oncology research program management and the development of imaging platforms. He has also worked in a hospital setting, where he developed a translational preclinical oncology platform for PDX and humanized mice in collaboration with clinicians. Ludovic’s move to industry began leading the preclinical and clinical evaluation of immuno-oncology programs, developing cancer vaccines using antibodies, from preclinical to phase I/IIa in CLL and solid tumor cancers. Ludovic’s team was responsible for conducting POC and non-clinical evaluation for the different programs as well as managing the preparation and presentation of non-clinical pharmacology sections of external documents (e.g. Investigator’s Brochure, IND/CTA, CTD).
As a pharmacologist with over 15 years of experience in the CRO/biotech industry and expertise in preclinical development of oncology drugs and vaccines, Ludovic is passionate about helping customers accelerate their early-stage drug development.
Register To Watch Recording
First Name*
Last Name*
Email Address*
Phone number*
Company / Organization*
Job Title*
Country / Region*
Main Area(s) of Research*
Clinical research
Drug discovery
Type of Organization*
Registration Terms
This event is hosted by the Scientist.com family of companies. Specific brands and sites associated with this event include InsideScientific. By registering and participating, you acknowledge that your personal data will be processed by the webinar platform (BigMarker), and InsideScientific. You also agree to receive email communication from InsideScientific about this webinar and other programs of similar nature. The sponsor of this webinar is SPONSOR; by registering and participating, you acknowledge that your data will be processed in accordance with SPONSOR's Privacy Policy. You will receive email communication from SPONSOR about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
Yes, I consent to the registration terms.*
Yes, I consent to the registration terms.*
Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.